Outset Medical, Inc. (OM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 50M 100M 150M FY18: 2M FY19: 15.1M FY20: 49.9M FY21: 102.6M FY22: 115.4M FY23: 130.4M FY24: 113.7M FY25: 119.5M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

-20M 0 20M 40M 60M FY18: -6.1M FY19: -17.8M FY20: -13M FY21: 7.6M FY22: 17.8M FY23: 29M FY24: 38.6M FY25: 46.8M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-180M -120M -60M 0 60M 120M 180M FY18: -46.6M FY19: -70.3M FY20: -117.5M FY21: -130.5M FY22: -161M FY23: -169.8M FY24: -113.4M FY25: -66.7M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-180M -120M -60M 0 60M 120M 180M FY18: -49.8M FY19: -68.3M FY20: -121.5M FY21: -131.9M FY22: -163M FY23: -172.8M FY24: -128M FY25: -81.7M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 35M 70M 105M FY18: 8.1M FY19: 32.9M FY20: 63M FY21: 95M FY22: 97.5M FY23: 101.4M FY24: 75.1M FY25: 72.7M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-150M -100M -50M 0 50M 100M 150M FY18: -46.4M FY19: -70.3M FY20: -99M FY21: -130.3M FY22: -145.7M FY23: -131.4M FY24: -116.3M FY25: -46.3M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-180M -120M -60M 0 60M 120M 180M FY18: -48.2M FY19: -73.6M FY20: -108.1M FY21: -133.4M FY22: -154.1M FY23: -134.8M FY24: -117.2M FY25: -47.1M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 20K 40K 60K FY20: 16.4K FY21: 45.6K FY22: 48.2K FY23: 3.3K FY24: 3.5K FY25: 15.2K FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-105.00 -70.00 -35.00 0.00 35.00 70.00 105.00 Q4 '19: -89.38 Q1 '21: -9.47 Q4 '19 Q1 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.